Stanford (Calif.) Medicine's primary care precision medicine project produced promising early results, according to a report published in Annals of Family Medicine.
The project, called Humanwide, combines genetic screening, biometric data from wearables, behavioral and social health assessments, wellness coaching, and coordinated care provided by a medical team. Stanford specifically hoped to identify patients at risk for developing cancer or cardiovascular disease and intervene to change their behaviors and prevent disease.
Stanford's primary care division began testing the concept in January 2018 on a group of 50 patients, diverse in age, race/ethnicity, sex and medical complexity. The pilot ran from January to July 2018. Stanford's team found early evidence that the interventions worked — the wearables helped identify multiple patients with early diabetes or hypertension and the genetic testing helped adjust medication dosage for others. The genetic testing also generated a lot of interest in the project and was the most common reason patients enrolled.
"Our early experience with Humanwide shows that creating a more comprehensive patient-centered data environment is feasible and acceptable to patients and providers," the authors wrote.
More articles on health IT:
Nanotech company demos wearable ECG to monitor fetal heart rate, mobility
AI can predict patient response to popular Crohn's treatment
Montana hospital selects athenahealth EHR: 3 things to know